We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+10.18%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$810M
AUM Growth
+$195M
Cap. Flow
+$133M
Cap. Flow %
16.42%
Top 10 Hldgs %
49.65%
Holding
195
New
66
Increased
84
Reduced
25
Closed
9

Top Buys

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$27.8M
2
AVDV icon
Avantis International Small Cap Value ETF
AVDV
+$17.5M
3
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$13.6M
4
SPTM icon
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
+$8.07M
5
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$6.73M

Top Sells

Rank Stock Value
1
DISV icon
Dimensional International Small Cap Value ETF
DISV
+$15.5M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$4.49M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.87M
4
INTF icon
iShares International Equity Factor ETF
INTF
+$2.82M
5
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$2.69M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.03%
2 Technology 3.22%
3 Healthcare 1.73%
4 Financials 1.6%
5 Real Estate 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
176
NVIDIA
NVDA
$5.25T
$205K 0.03%
+14,060
New +$206K
FITB
177
Fifth Third Bancorp
FITB
$49.5B
$200K 0.02%
+6,103
New +$208K
TARS icon
178
Tarsus Pharmaceuticals
TARS
$3.15B
$170K 0.02%
+11,600
New +$192K
ALLO icon
179
Allogene Therapeutics
ALLO
$698M
$121K 0.01%
+19,224
New +$178K
EQ icon
180
Equillium
EQ
$152M
$110K 0.01%
+103,688
New +$166K
INFI
181
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$88K 0.01%
+158,500
New +$135K
CDTX
182
DELISTED
Cidara Therapeutics
CDTX
$78.2K 0.01%
+5,173
New +$61.7K
SRXH
183
SRX Global
SRXH
$34.7M
$23.3K ﹤0.01%
+22
New +$36.1K
CRDF icon
184
Cardiff Oncology
CRDF
$73.1M
$19K ﹤0.01%
+13,587
New +$19.5K
EFTR
185
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$8.55K ﹤0.01%
800
– –
BOND icon
186
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
– –
-9,264
Closed -$831K
FLOT icon
187
iShares Floating Rate Bond ETF
FLOT
$10.6B
– –
-5,000
Closed -$251K
MUB icon
188
iShares National Muni Bond ETF
MUB
$45.5B
– –
-10,600
Closed -$1.09M
PFF icon
189
iShares Preferred and Income Securities ETF
PFF
$13.1B
– –
-7,900
Closed -$250K
SPYV icon
190
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
– –
-14,545
Closed -$502K
TFI icon
191
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.09B
– –
-5,387
Closed -$237K
TIP icon
192
iShares TIPS Bond ETF
TIP
$15B
– –
-3,500
Closed -$367K
USHY icon
193
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29B
– –
-12,700
Closed -$427K
VCIT icon
194
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
– –
-18,540
Closed -$1.4M
4 5 6 7
8

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Callan Capital held 195 positions worth $810M, up 32% from $614M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Callan Capital deployed $133M of net new capital in Q4 2022, opening 66 new positions and adding to 84 existing holdings. Its largest new stake was Home BancShares: 247,233 shares worth $5.63M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Dimensional International Small Cap Value ETF, an estimated $15.5M trimmed.

  • Callan Capital's largest Q4 2022 buy was Home BancShares: 247,233 shares worth $5.63M.
  • Callan Capital added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $27.8M increase.
  • Callan Capital's biggest Q4 2022 reduction was Dimensional International Small Cap Value ETF, cutting an estimated $15.5M.
  • Callan Capital fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q4 2022, selling an estimated $1.4M.
  • Callan Capital's ten largest holdings make up 50% of its $810M portfolio in Q4 2022.
  • Callan Capital opened 66 new positions and closed 9 in Q4 2022.
  • Callan Capital's portfolio value rose 32% quarter-over-quarter to $810M.

Based on Callan Capital's 13F filing for Q4 2022, filed 13 Feb 2023.